People hospitalized for infections—almost any infections—are at substantially increased risk years later for heart failure, ...

A new study comparing multiple and single arterial grafting highlights how physician preference can bias observational data.

An Instagram reel claims that Blood Pressure can get normal by onion juice. The claim by the user is Misleading.ClaimIn an ...

AngioDynamics, Inc. ANGO recently announced the initiation of a clinical study, AMBITION BTK, comparing the Auryon Atherectomy System Used in Combination with Standard Balloon Angioplasty with ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...

University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage. If approved, the ...

Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.

People with acid reflux often rely on acid-reducing medications to ease symptoms. Depending on the severity of your symptoms, over-the-counter (OTC) and prescription options are available.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.